to prog. Follow - up8 Immunization R X X X Physical Examination S X X X X Adverse Event Assessments R X X X X Performance Status S X X X X X X X Vital Signs S X X X X X X X Weight S X X X X X X X Blood for PSA & PAP2 S/R X X (R) X (R) X X X X X anti-PSA Ab, and lymphocytes for cellular immunity R X X X X X X X7 X7 X7 X9 CBC, differential R X X X X X X X X9 AST, ALT, LDH, alkaline phosphatase, bilirubin R X X X X Creatinin e R X X X X Urinalysis R X X X X Chest x -ray R X5 X5 X5 X5 Bone scan S X X6 X6 X6 X6 X6 Abdominal/pelvic CT S X X6 X6 X6 X6 X6 Serum testosterone3 R X X Begin ADT3, 4 S X X Survival asse ssment R X8 S = Procedures considered “Standard of Care” for prostate cancer patients. R = Procedures considered “Research” as part of this Clinical Trial.